BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Affonso BB, Galastri FL, da Motta Leal Filho JM, Nasser F, Falsarella PM, Cavalcante RN, de Almeida MD, Felga GEG, Valle LGM, Wolosker N. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging. World J Gastroenterol 2019; 25(37): 5687-5701 [PMID: 31602168 DOI: 10.3748/wjg.v25.i37.5687]
URL: https://www.wjgnet.com/1948-5182/full/v25/i37/5687.htm
Number Citing Articles
1
Cyrill Wehling, Michael T. Dill, Alexander Olkus, Christoph Springfeld, De-Hua Chang, Patrick Naumann, Thomas Longerich, Clemens Kratochwil, Arianeb Mehrabi, Uta Merle, Jan Pfeiffenberger, Christian Rupp, Karl Heinz Weiss, Markus Mieth. Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunitiesJournal of Cancer Research and Clinical Oncology 2021; 147(8): 2471 doi: 10.1007/s00432-021-03528-3
2
Rubén Caiña Ruiz, Enrique Toledo Martínez, Edward Joseph Anderson, Víctor Valbuena Jabares, Roberto Fernández Santiago, Federico Castillo, Juan Echeverri, Mar Achalandabaso, Francisco José González Sánchez, Emilio Fábrega, Antonio Cuadrado, José Ignacio Fortea, Javier Crespo, Juan Carlos Rodríguez Sanjuán. Effect of Bridging Therapy on Survival in Hepatocellular Carcinoma Patients Who Receive Liver TransplantsTransplantation Proceedings 2022; 54(9): 2528 doi: 10.1016/j.transproceed.2022.09.007
3
Kelley G. Núñez, Tyler Sandow, Daniel Fort, Mina Hibino, Paige Wright, Ari J. Cohen, Paul T. Thevenot. PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survivalCancer Immunology, Immunotherapy 2022; 71(6): 1453 doi: 10.1007/s00262-021-03087-z
4
Kohei Ogawa, Yasutsugu Takada. Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver TransplantationCancers 2022; 14(2): 396 doi: 10.3390/cancers14020396
5
Allison B. Couillard, Emily A. Knott, Annie M. Zlevor, Joshua D. Mezrich, Mircea M. Cristescu, Parul Agarwal, Timothy J. Ziemlewicz, Colin Longhurst, Meghan G. Lubner, J. Louis Hinshaw, Adnan Said, Paul F. Laeseke, Michael R. Lucey, John P. Rice, David Foley, David Al-Adra, Fred T. Lee. Microwave Ablation as Bridging to Liver Transplant for Patients with Hepatocellular Carcinoma: A Single-Center Retrospective AnalysisJournal of Vascular and Interventional Radiology 2022; 33(9): 1045 doi: 10.1016/j.jvir.2022.05.019
6
Chao Jiang, Xiao-Dong Sun, Wei Qiu, Yu-Guo Chen, Da-Wei Sun, Guo-Yue Lv. Conversion therapy in liver transplantation for hepatocellular carcinoma: What's new in the era of molecular and immune therapy?Hepatobiliary & Pancreatic Diseases International 2023; 22(1): 7 doi: 10.1016/j.hbpd.2022.10.006
7
Ana-Maria Bucalau, Illario Tancredi, Gontran Verset. In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?Cancers 2021; 13(20): 5129 doi: 10.3390/cancers13205129
8
Deniz Can Guven, Hasan Cagri Yildirim, Elvin Chalabiyev, Fatih Kus, Feride Yilmaz, Serkan Yasar, Arif Akyildiz, Burak Yasin Aktas, Suayib Yalcin, Omer Dizdar. Emerging treatment strategies in hepatobiliary cancerExpert Review of Anticancer Therapy 2023; 23(3): 243 doi: 10.1080/14737140.2023.2183844
9
Roberto Minici, Maria Anna Siciliano, Michele Ammendola, Rita Carlotta Santoro, Vito Barbieri, Girolamo Ranieri, Domenico Laganà. Prognostic Role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: The Unexplored Corner Linking Tumor Microenvironment, Biomarkers and Interventional RadiologyCancers 2022; 15(1): 257 doi: 10.3390/cancers15010257
10
Leonardo Guedes Moreira Valle, Marcela Juliano Silva Cunha, Bruno Pagnin Schmid, Priscila Mina Falsarella, Marcelo Bruno de Rezende, Guilherme Eduardo Gonçalves Felga, Renata Emy Ogawa, Rodrigo Gobbo Garcia, Breno Boueri Affonso, Felipe Nasser, Francisco Leonardo Galastri. Radiological characteristics of hepatocellular carcinoma that achieved complete response after chemoembolization with drug-eluting beads for liver transplantation planningeinstein (São Paulo) 2023; 21 doi: 10.31744/einstein_journal/2023AO0307
11
Abu Bakar Hafeez Bhatti, Muhammad Hassan, Atif Rana, Nusrat Yar Khan, Zahid Amin Khan, Haseeb Haider Zia. Risk Score Model for Liver Transplant Outcomes after Preoperative Locoregional Therapy for Hepatocellular CarcinomaJournal of Gastrointestinal Cancer 2022; 53(1): 84 doi: 10.1007/s12029-020-00554-1
12
Joseph W. Franses, Andrew X. Zhu. Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the PresentClinical Cancer Research 2022; 28(13): 2738 doi: 10.1158/1078-0432.CCR-22-0025
13
Joaquim Maurício da Motta-Leal-Filho. Locoregional therapies for the treatment of locally advanced hepatocellular carcinomaRadiologia Brasileira 2021; 54(3): IX doi: 10.1590/0100-3984.2021.54.3e3
14
Thiago José Penachim. A valuable tool for the treatment of hepatocellular carcinomaRadiologia Brasileira 2023; 56(5): VII doi: 10.1590/0100-3984.2023.56.5e2
15
Roberto Iezzi, Alessandro Posa, Andrea Contegiacomo, In Joon Lee, Reto Bale, Alessandro Tanzilli, Lorenzo Tenore, Felice Giuliante, Antonio Gasbarrini, Shraga Nahum Goldberg, Tobias Jakobs, Maurizio Pompili, Irene Bargellini, Evis Sala, Hyo-Cheol Kim. Early-Stage HCC Percutaneous Locoregional Management: East versus West PerspectivesCancers 2023; 15(15): 3988 doi: 10.3390/cancers15153988
16
Liang Cai, Honglu Li, Jiang Guo, Wenpeng Zhao, Youjia Duan, Xiaopu Hou, Long Cheng, Hongliu Du, Xihong Shao, Zhenying Diao, Changqing Li. Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort studyClinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101535 doi: 10.1016/j.clinre.2020.09.002
17
Brett Marinelli, Mario Cedillo, Sara D. Pasik, Dudley Charles, Shashi Murthy, Rahul S. Patel, Aaron Fischman, Monda Ranade, Vivian Bishay, Scott Nowakowski, Max Sung, Thomas Marron, Robert Lookstein, Myron Schwartz, Edward Kim. Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 PatientsJournal of Vascular and Interventional Radiology 2020; 31(11): 1729 doi: 10.1016/j.jvir.2020.07.009
18
Guangjiang Jiang, Sunbin Ling, Qifan Zhan, Li Zhuang, Xiao Xu. Downstaging treatment for patients with hepatocelluar carcinoma before transplantationTransplantation Reviews 2021; 35(2): 100606 doi: 10.1016/j.trre.2021.100606
19
Haoran Huo, Xiaoying Wang, Shan Xu, Xiaotong Niu, Limin Cheng, Zengjiang Yuan, Shuang Huo, Pingping Fang. Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate‑stage hepatocellular carcinoma: A pilot studyOncology Letters 2023; 26(5) doi: 10.3892/ol.2023.14052
20
Marcello Di Martino, Alessandro Vitale, Daniele Ferraro, Marilisa Maniscalco, Donatella Pisaniello, Giuseppe Arenga, Federica Falaschi, Alfonso Terrone, Alessandro Iacomino, Alfonso Galeota Lanza, Ciro Esposito, Umberto Cillo, Giovanni Vennarecci. Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat OutcomesCancers 2022; 14(20): 5102 doi: 10.3390/cancers14205102
21
宁宁 胡. Effect of Preoperative Treatment on Survival of Patients with Hepatocellular Carcinoma after Liver TransplantationAdvances in Clinical Medicine 2023; 13(03): 2903 doi: 10.12677/ACM.2023.133411
22
Giacomo Zanus, Giovanni Tagliente, Serena Rossi, Alessandro Bonis, Mattia Zambon, Michele Scopelliti, Marco Brizzolari, Ugo Grossi, Maurizio Romano, Michele Finotti. Pulsed Microwave Liver Ablation: An Additional Tool to Treat Hepatocellular CarcinomaCancers 2022; 14(3): 748 doi: 10.3390/cancers14030748
23
Zongyi Yin, Dongying Chen, Shuang Liang, Xiaowu Li. Neoadjuvant Therapy for Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2022; : 929 doi: 10.2147/JHC.S357313
24
Silvia Cesario, Virginia Genovesi, Francesca Salani, Enrico Vasile, Lorenzo Fornaro, Caterina Vivaldi, Gianluca Masi. Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy RevolutionLife 2023; 13(7): 1562 doi: 10.3390/life13071562
25
Alfonso Jose Holguín Holguín, Juan Sebastián Toro Gutierrez, Luis Alfonso Bustamante-Cristancho, Tatiana Alvarez Saa, Juan C. Camacho. Bland Embolization and Transarterial Chemoembolization in HepatocarcinomaDigestive Disease Interventions 2024; 8(01): 52 doi: 10.1055/s-0043-1772742
26
Roberto Minici, Michele Ammendola, Francesco Manti, Maria Anna Siciliano, Marco Minici, Iman Komaei, Giuseppe Currò, Domenico Laganà. Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in the Downstaging of Intermediate-Stage Hepatocellular Carcinoma (HCC) in Patients With a Child-Pugh Score of 8-9Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.634087
27
Laura Crocetti, Elena Bozzi, Paola Scalise, Irene Bargellini, Giulia Lorenzoni, Davide Ghinolfi, Daniela Campani, Emanuele Balzano, Paolo De Simone, Roberto Cioni. Locoregional Treatments for Bridging and Downstaging HCC to Liver TransplantationCancers 2021; 13(21): 5558 doi: 10.3390/cancers13215558
28
Basheer Elsolh, Zubair Bayat, Dennis Lyu, Jules Lin, Elliot Wakeam. Lung transplantation for lung cancer: A systematic review of the literatureThe Journal of Heart and Lung Transplantation 2023; 42(10): 1425 doi: 10.1016/j.healun.2023.05.011
29
Takeshi Takamoto, Yuta Maruki, Shunsuke Kondo. Recent updates in the use of pharmacological therapies for downstaging in patients with hepatocellular carcinomaExpert Opinion on Pharmacotherapy 2023; 24(14): 1567 doi: 10.1080/14656566.2023.2229728
30
Yanxu Li, Hao Zou, Zekun Zheng, Zhuoheng Liu, Huiyuan Hu, Wei Wu, Tao Wang. Advances in the Study of Bioactive Nanoparticles for the Treatment of HCC and Its Postoperative Residual CancerInternational Journal of Nanomedicine 2023; : 2721 doi: 10.2147/IJN.S399146
31
Hui-Chuan Sun, Xiao-Dong Zhu. Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An OverviewFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.772195